Briefing: CRISPR-based technique unlocks healing power of mitochondria for heart failure therapy
Strategic angle: A groundbreaking approach using CRISPR technology shows promise in treating heart failure by enhancing mitochondrial function.
Editorial Staff
1 min read
Updated 4 months ago
Heart failure affects 6.8 million Americans.
One-third of heart attack survivors develop heart failure.
The technique aims to improve energy recovery in heart cells.